Olanzapine impurity L HCl

CAS No. 138564-60-0

Olanzapine impurity L HCl( —— )

Catalog No. M35876 CAS No. 138564-60-0

Olanzapine impurity L HCl is an impurity generated during the production of Olanzapine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 48 In Stock
10MG 67 In Stock
25MG 107 In Stock
50MG 152 In Stock
100MG 222 In Stock
200MG Get Quote In Stock
500MG 548 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Olanzapine impurity L HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    Olanzapine impurity L HCl is an impurity generated during the production of Olanzapine.
  • Description
    Olanzapine impurity L HCl is an impurity generated during the production of Olanzapine.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    138564-60-0
  • Formula Weight
    265.76
  • Molecular Formula
    C12H12ClN3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.N1=C(N)C=2C=C(SC2NC=3C=CC=CC13)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • AC 7739

    AC 7739 is a microtubule protein binding agent with anticancer and antitumor activity that inhibits advanced solid tumors and in situ transplanted tumors.

  • L-Threonic acid magn...

    L-Threonic acid magnesium salt (L-TAMS) increases synapse density and memory ability in both aged rats and late stage Alzheimer’s disease (AD) model mice.

  • Neuropeptide W-30 (r...

    Neuropeptide W-30 (rat) is an important stress mediator in the central nervous system that modulates the hypothalamus-pituitary-adrenal (HPA) axis and sympathetic outflow. Neuropeptide W-30 (rat) is an endogenous ligand for the two structurally related orphan G-protein-coupled receptors (GPCRs) GPR7 and GPR8. NPW-30 activates and binds to both GPR7 and GPR8 at similar effective doses.